Equities

Reuters exclusively reports on Big Pharma’s planned return to U.S. price hikes in January

Reuters exclusively reports on Big Pharma’s planned return to U.S. price hikes in January

Reuters exclusively reported that nearly 30 drugmakers are set to raise the U.S. prices of their medicines in January, ending a self-declared halt to increases made by the pharmaceuticals industry under pressure from the Trump administration. The story revealed that Novartis, Bayer, Amgen, GSK and others are among the manufacturers ready to resume price hikes in a challenge to U.S. President Donald Trump, who has promised relief to consumers struggling with the rising cost of their medicines.


ARCHIVE

Search on topics and regions relevant to your business.

Go to archive